CIK 0000034956 · Non-accelerated filer<br>Smaller reporting company
TENAX THERAPEUTICS, INC.
Sign in to watch- Ticker
- TENX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 262593535
- Phone
- 919-855-2100
- Business address
- 101 GLEN LENNOX DRIVE, SUITE 300, CHAPEL HILL, NC, 27517
- Former names
- OXYGEN BIOTHERAPEUTICS, INC., SYNTHETIC BLOOD INTERNATIONAL INC
- 424B3 Offering Prospectus
- 8-K Event Other events
- CORRESP Other Correspondence Between Filers and SEC Staff
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- 424B3 Offering Prospectus
- 8-K Event Other events
- 424B3 Offering Prospectus
- 3 Insider Initial Statement of Ownership
- 8-K Event Delisting notice · Executive or director change
- 424B3 Offering Prospectus
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change · Other events
- UPLOAD Other SEC-generated Letter
- 424B3 Offering Prospectus
- S-1 Offering Registration Statement
- 8-K Event Shareholder vote results
- 424B3 Offering Prospectus
- 10-Q Report Quarterly Report
Page 12 of 50 · 996 filings